Kimberly Rohan
Oncology · Naperville, ILNPI 1982749750
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $142,059 of the $192,181 with a category attached, or 73.9%. 36 manufacturers reported payments, led by AstraZeneca at 40.2% of the total.
Across 386 payments — averaging $497.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$77K
- Regeneron Healthcare Solutions, Inc.$73K
- Sanofi$17K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- G1 Therapeutics, Inc.$5K
- Pharmacosmos Therapeutics Inc.$4K
- plus $10K from 30 others
What the payments were for
- Consulting fees$10,8916%
- Speaking & faculty fees$142,05974%
- Travel & lodging$29,08415%
- Food & beverage$8,8995%
- Education$1,2481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 99 | $77,285 |
| Regeneron Healthcare Solutions, Inc. | 135 | $73,033 |
| Sanofi | 28 | $16,836 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $6,135 |
| G1 Therapeutics, Inc. | 9 | $4,914 |
| Pharmacosmos Therapeutics Inc. | 7 | $4,360 |
| Genentech USA, Inc. | 13 | $3,065 |
| Epizyme, Inc. | 7 | $1,899 |
| Seagen Inc. | 5 | $814 |
| Janssen Scientific Affairs, LLC | 1 | $680 |
| E.r. Squibb & Sons, L.L.C. | 6 | $409 |
| Merck | 15 | $403 |
| Astellas Pharma US Inc | 4 | $322 |
| Gilead | 3 | $311 |
| Lilly USA, LLC | 9 | $291 |
| Sanofi-aventis U.S. LLC | 3 | $276 |
| Amgen | 5 | $201 |
| Telix Pharmaceuticals | 1 | $123 |
| Eisai Inc. | 1 | $120 |
| Bayer | 2 | $118 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $98 |
| Johnson & Johnson(2 entities) | 3 | $64 |
| Incyte Corporation | 2 | $58 |
| Adaptive Biotechnologies Corporation | 2 | $48 |
| Novartis | 2 | $47 |
| Global Blood Therapeutics, Inc. | 2 | $45 |
| AbbVie | 1 | $32 |
| Terumo Medical Corporation | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Cardinal Health 414 LLC | 1 | $24 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $19 |
| Novocure Inc. | 2 | $19 |
| Foundation Medicine, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few oncology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Other oncology in Naperville
- Margaret GregusHinsdale$1K
- Barbara GordonChicago$875
- Carla SmithQuincy$489
- Evelyn GallinaitisMaywood$365
- Jill BenedeckMcHenry$294
- Melissa ArangoaChicago$281
- Magan SchwartzWarrenville$215
- Karen GiammicchioSchaumburg$156
- Mona SeaverGeneva$153
- Maryanne FishmanChicago$120
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.